Concepedia

Rachel Talbot

RT

Statistics

Publications

7

Citations

173

H-Index

7

Active since

2020

Affiliations

Institute of Cancer Research(Current)

University of California, Davis

Rachel Talbot is an author at Institute of Cancer Research specializing in drug discovery, ligand binding, and potency optimization.

ORCID

Publications per year

2020–2023

7

Publications

7

Achieving <i>In Vivo</i> Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ana Varela et al. · Journal of Medicinal Chemistry · 2020 · 73 citations · Full text

, , +11

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors

Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

, , +15

Quantifying Polaron Mole Fractions and Interpreting Spectral Changes in Molecularly Doped Conjugated Polymers

Adam J. Moulé, Goktug Gonel, Tucker L. Murrey et al. · Advanced Electronic Materials · 2021 · 22 citations · Full text

, , +16

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Matthew G. Lloyd, Rosemary Huckvale, Kwai-Ming J. Cheung et al. · Journal of Medicinal Chemistry · 2021 · 16 citations · Full text

, , +17

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 <i>In Vivo</i>

Rosemary Huckvale, Alice C. Harnden, Kwai-Ming J. Cheung et al. · Journal of Medicinal Chemistry · 2022 · 14 citations · Full text

, , +7

1–5 of 7